Navigation Links
Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry
Date:12/10/2007

Strengthens DBI's Portfolio of Technologies for Enabling Faster, Easier Quantification of Protein Biomarkers in Translational Medicine and Adaptive

Clinical Trials

WALTHAM, Mass., Dec. 10 /PRNewswire/ -- Decision Biomarkers Inc (DBI), a leading developer of protein biomarker analysis systems for pharmaceutical research and development, today announced the company's PATH(R) technology has been awarded United States Patent 7,297,497 by the U.S. Patent and Trademark Office. The patent applies to a novel, ultra-thin nitrocellulose surface chemistry that enables the detection of low-abundance proteins. This technology is integrated into DBI's AVANTRA(TM)Q400 Biomarker Workstation, a new, easy-to-use, immunoassay system that enables non-specialized technicians to perform complex protein biomarker analyses in the lab or directly at a clinical trial site.

Protein microarray glass slides utilizing the PATH(R) technology are also available from leading life science consumable suppliers to enable researchers to perform ultra sensitive assays including sandwich immunoassays, capture immunoassays, protein profiling, and protein characterization.

"Nitrocellulose has proven to be the protein-assay substrate of choice for decades. With this technology, researchers can use a wide variety of fluorescence probes to make protein assays easier, faster and more sensitive than ever before," said Roger Dowd, CEO and President of DBI. "By delivering a high signal-to-noise ratio and low background fluorescence, we believe the PATH(R) surface chemistry to be far superior to other commercially available protein-array surfaces."

The AVANTRA(TM)Q400 Biomarker Workstation, DBI's flagship product, is commercially available with various protein biomarker content including "off-the-shelf" multiplex biomarker panels for oncology, immunology, and cardiology, along with custom content defined by the Company's collaborators.

About D
'/>"/>

SOURCE Decision Biomarkers Inc
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Consumer Advocates Praise Interstate Stem Cell Open Meeting Decision
2. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
3. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
4. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
5. New Data Reveal Ethnicity May Play Role in Weight Loss Decisions
6. Genta Completes Appeal of FDA Decision for Genasense(R) in CLL
7. NPS Pharmaceuticals to Report Third Quarter 2007 Financial Results and Nycomed Decision on GATTEX(TM) Partnership on November 1, 2007
8. Scientists Using Social Media to Inform Lab Purchasing Decisions
9. Ingenuity Systems Joins Biomarkers Consortium
10. GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
11. Mirus Bio Awarded Grants & Contracts of Over $5 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2008)...nues Increase Over 29% From Previous Quarter, NEW...l Inc. (OTC:,SPOM), a leading developer of biosens...able monitoring devices, announced its first quart...Gross revenues for the period were US$1,079,000, a...ues. The increase in revenues was mainly,attribute...
(Date:5/15/2008)...o., May 15 /- Baxa Corporation, a,Den...thcare systems, has,won two 2008 Business Marketin...irect mail campaign featuring the PadLock(R) Set-S...med marketing competitions, the BMA,Gold Key Award... at the,Cable Center at the University of Denver. ...
(Date:5/15/2008)...ill Support Phase 3 Lead Clinical Pain Program for...JOLLA, Calif., May 15 /- Tr...TDLP), a specialty,pharmaceutical company focused ...vasive topically administered medications, today a...ment of its common stock and warrants., The Compa...
(Date:5/15/2008)...May 15 /Xinhua-- Huifeng Bi...oard: HFGB), a leading,developer and producer of p... use in pharmaceutical, nutraceutical and food pro...incurred to their facilities as a result,of the Si...hquake, local Xi,an government officials,ordered a...
Breaking Biology Technology:SPO Medical Reports First Quarter 2008 Results 2SPO Medical Reports First Quarter 2008 Results 3Baxa Corporation Wins Two Colorado BMA 2008 Gold Key Awards 2Baxa Corporation Wins Two Colorado BMA 2008 Gold Key Awards 3Transdel Pharmaceuticals Closes $4 Million Financing 2Transdel Pharmaceuticals Closes $4 Million Financing 3Huifeng Bio-Pharmaceutical (HFGB) Announces No Earthquake Related Damage to Facilities 2
...ub of Chicago presented its annual outlook for the...Hilton, the guest speakers were Robert J. Dr. Bob ...rray of the Wall Street Journal , and Diane Swonk...lumnist Terry Savage moderated the panel and some .... , , Comparing last year to this year , ,Savage ...
... Miszewski will leave his job as administrator of ...he end of February, about the time an audit on pro...due to be released. , ,Miszewski, who likely will ...ed his staff of the decision in an e-mail and prai... in government. , ,His efforts generally have rec...
...nsin companies raised more venture capital in more...nal in both categories, according to report from ...,Companies in Wisconsin reported 12 venture deals ...leGen Systems , a Madison-based maker of genomic r...total, up from the $55.69 million reported in 2005...
...ilFoundry , a provider of anti-spam appliances and...chnology to combat new spam tactics known as bo...y attacks . , ,The company,s chief executive said ...ts MessageIQ anti-spam engine, defeats botnet spam...ction capabilities. , ,David C. Troup, CEO and fou...
Other Biology Technology:Economic outlook for 2007, and still clueless on Apple 2Economic outlook for 2007, and still clueless on Apple 3Economic outlook for 2007, and still clueless on Apple 4Economic outlook for 2007, and still clueless on Apple 5Miszewski to depart as state IT audit wraps up 2Wisconsin fares slightly better in venture capital chase 2Wisconsin fares slightly better in venture capital chase 3
(Date:5/15/2008)...CAMBRIDGE, Mass.--MIT engineers have improved the ... 50 percent through technology that could help the... find a much broader market, particularly in porta...ork is also considerably less expensive than its c...vantages. , Our goal is to replace traditional f...
(Date:5/15/2008)...LA JOLLA, CA - Now that high school biology studen... transcribed into messenger RNA (mRNA), which is t...ss of molecules, sending studentsand many scientis... Salk Institute for Biological Studies investigato...8 online issue of Developmental Cell, shows that t...
(Date:5/15/2008)...Stowers Institute researchers Karen Staehling-Hamp..., and Olivier Pourqui, Ph.D., Investigator, collab...ow that genes known to cause spinal mutations in c...t role in human patients with congenital vertebral...oday on the Web site of the American Journal of Hu...
(Date:5/15/2008)...Fishermen hold empirical knowledge that tuna aggre...d rope, pieces of wood, or even large marine mamma...gregation behaviour, but the past 20 years have se... the associated concentrations of fish. Fishermen ...act as FADs. An enormous purse-seine net, deployed...
Breaking Biology News(10 mins):MIT creates new material for fuel cells 2MIT creates new material for fuel cells 3Plant biologists discover unexpected proteins affecting small RNAs 2Plant biologists discover unexpected proteins affecting small RNAs 3Stowers Institute researchers identify gene linked to vertebral defects in patient populations 2Does fishing on drifting fish aggregation devices endanger the survival of tropical tuna? 2Does fishing on drifting fish aggregation devices endanger the survival of tropical tuna? 3Medarex to Present at the 26th Annual JPMorgan Healthcare Conference 2424 1Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals 2421 1Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals 2421 2NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF 03187207 in Japan 1128 1NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF 03187207 in Japan 1128 2NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF 03187207 in Japan 1128 3PolyOne Completes Acquisition of GLS Corporation 9001 1PolyOne Completes Acquisition of GLS Corporation 9001 2PolyOne Completes Acquisition of GLS Corporation 9001 3PolyOne Completes Acquisition of GLS Corporation 9001 4
...new study published in the open-access journal PLo...trophic collapse in orangutan populations living i...ife Sanctuary in Sabah, Malaysia. Benoit Goossens,...leagues report that the collapse occurred within t...past decades--coinciding with massive deforestatio...
...ch year, the red knot, a medium-sized shorebird, m...p of Argentina to the Artic Circle ?one of the lon...ril to June, the red knot stops over in the Delawa...om the largest spawning of horseshoe crabs found o...ers from Virginia Tech and the New Jersey Division...
...new study, to be published in a forthcoming issue ...e prospective gains that could be obtained from fu...rphy and Robert H. Topel, two University of Chicag...nts against major diseases would have a significan...cancer has a value to Americans of nearly $500 bil...
...op yields on farms in developing countries that us...in four years, according to a study scheduled for ...hemical Society journal Environmental Science &a...d to date -- 286 farm projects in 57 countries -- ...e environment in these countries while substantial...
Other Biology News:Genetic study shows humans have pushed orangutans to the brink of extinction 2Horseshoe crab decline threatens shorebird species 2
...atulas have been designed to save time and provide...terested in eliminating the recycling and resteril...la is individually packaged, RNase/DNase free, non...r is a new product number, created to easily match...
... (PR) Competitor Assay Kits are ideal for studying...compounds using fluorescence polarization (FP) The... transferase to the ligand binding domain of human...tary, fluorescently-tagged progesterone ligand, Fl...
...tors combine the proven features of the pET, BacVe... of the benefits and versatility of each expressio...s have been extensively tested for performance wit...tems. In each case, expression was similar to that...
Rabbit polyclonal to Shigella Immunogen: Mixture of S. boydii, S. flexneri & S. dysenteriae.
Biology Products: